Cargando…
Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Pancreatic cancer is an aggressive cancer of the digestive system, which is becoming a serious health problem worldwide. Overall survival for patients with pancreatic cancer is poor, mainly due to a lack of biomarkers to enable early diagnosis and a lack of prognostic markers that can inform decisio...
Autores principales: | Previdi, Maria C, Carotenuto, Pietro, Zito, Domenico, Pandolfo, Rosantony, Braconi, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253462/ https://www.ncbi.nlm.nih.gov/pubmed/27841659 http://dx.doi.org/10.2217/fon-2016-0253 |
Ejemplares similares
-
The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know
por: Zhou, Wenjia, et al.
Publicado: (2020) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008) -
Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023) -
The Role of Testosterone in the Elderly: What Do We Know?
por: Barone, Biagio, et al.
Publicado: (2022)